Identifying a New Growth Hormone Peptide Receptor in the Pituitary | Research

The takeaway

Photoaffinity labeling revealed a specific GHRP receptor subtype in pituitary cells with distinct binding properties, supporting the existence of multiple GH secretagogue receptor types.

Receptor protein identified
Physical identification of a GHRP-specific receptor by photoaffinity labeling confirmed pharmacological predictions of multiple receptor subtypes

What the researchers found

Photoaffinity labeling with modified hexarelin identified a specific GHRP receptor protein in pituitary membranes, confirming the existence of a distinct GH secretagogue receptor subtype.

Why it matters

Physically identifying the GHRP receptor protein was essential for eventually cloning it, which led to the discovery of ghrelin and the broader understanding of how these peptides work in the body.

How the study worked

In-vitro receptor identification study using photoaffinity labeling with a benzophenone-modified hexarelin analog on rat and human pituitary membranes. SDS-PAGE and autoradiography were used to identify labeled proteins.

What this study cannot tell us

Technical receptor identification study. Photoaffinity labeling can produce artifacts. The functional significance of the identified protein was not established in this study alone.

How to read the evidence

Preliminary evidence from a specialized receptor identification technique. Important for receptor biology but limited to in-vitro characterization.

When this study was published

Published in 1998. The GH secretagogue receptor was cloned shortly after, and is now known as the ghrelin receptor (GHS-R1a).

The bigger picture

Identifying receptors at the molecular level is a crucial step from pharmacology to drug development. This work contributed to the eventual cloning of the GH secretagogue receptor (now called the ghrelin receptor), which has become a major drug target.

Questions still open

Can this receptor be cloned and expressed for drug screening?
Does this receptor subtype correspond to specific GHRP biological effects?
Are there additional undiscovered GHRP receptor proteins?

Common questions

What is photoaffinity labeling?

It's a technique where a drug molecule is modified to permanently attach to its receptor when exposed to light. This allows researchers to physically identify the receptor protein, a crucial step toward understanding how drugs work at the molecular level.

Why does identifying the receptor matter?

Knowing the exact receptor protein allows scientists to clone it, study its structure, and design better drugs that target it precisely. This work contributed to identifying the ghrelin receptor, now a major therapeutic target.

Read the original research

Identification of a pituitary growth hormone-releasing peptide (GHRP) receptor subtype by photoaffinity labeling.

Endocrinology, 139(1), 432-5

View on PubMed ↗

Citation

Ong, H; McNicoll, N; Escher, E; Collu, R; Deghenghi, R; Locatelli, V; Ghigo, E; Muccioli, G; Boghen, M; Nilsson, M. (1998). Identification of a pituitary growth hormone-releasing peptide (GHRP) receptor subtype by photoaffinity labeling.. Endocrinology, 139(1), 432-5.